InvestorsHub Logo
Followers 0
Posts 6
Boards Moderated 0
Alias Born 10/17/2017

Re: Stefa post# 768

Monday, 02/05/2018 12:12:03 PM

Monday, February 05, 2018 12:12:03 PM

Post# of 1248
Unfortunately, I agree --unless 4th quarter earnings are a blow-out, which is unlikely --probably reverse 5 to 1, it they are smart, otherwise 10 to 1, which I do not think is smart, because the float will be too thin. Of course, they could always dilute with another offering. Biolase's stockholders best bet might be the company's acquisition by a Chinese company. Sorry to be down on this stock, but same old, same old is just not working.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIOL News